Skip to main content
. 2021 Aug 27;11:17305. doi: 10.1038/s41598-021-95998-1

Table 2.

Comparison of pregnancy outcomes among the four groups.

Outcome Control group (n = 437,382) Women with α-thalassemia trait P1* (P2)
Normal fetal group (n = 446) Fetal group with α-thalassemia trait (n = 708) Fetal group with HbH disease (n = 211)
Cesarean delivery 127,851 (29.23) 137 (30.72) 208 (29.38) 63 (29.86) 0.889 (.914)
Postpartum hemorrhage 14,232 (3.25) 24 (5.38) 30 (4.24) 9 (4.27) 0.643 (.026)
Birth before 34 weeks of gestation 5221 (1.19) 8 (1.79) 6 (0.85) 4 (1.90) 0.283 (.398)
Birth before 37 weeks of gestation 25,205 (5.76) 25 (5.61) 48 (6.78) 17 (8.06) 0.477 (.333)
Fetal growth restriction 9198 (2.10) 7 (1.57) 15 (2.12) 6 (2.84) 0.551 (.758)
Low birth weight 22,695 (5.19) 23 (5.16) 40 (5.65) 19 (9.00) 0.129 (.088)
Macrosomia 12,986 (2.97) 13 (2.91) 27 (3.81) 6 (2.84) 0.640 (.622)
Apgar score < 7 at 1 min 4034 (0.92) 7 (1.57) 9 (1.27) 10 (4.74) 0.004 (< .001)
Apgar score < 7 at 5 min 1918 (0.44) 3 (0.67) 1 (0.14) 6 (2.84) 0.001 (.001)
Perinatal death 1874 (0.43) 1 (0.22) 1 (0.14) 2 (0.95) 0.147 (.359)

Data are n (%) unless otherwise specified. *Chi-squared or Fisher–Freeman–Halton exact test for three subgroups. Chi-squared or Fisher–Freeman–Halton exact test for all groups.